These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 6793024)

  • 21. Diurnal variations in plasma neutral amino acid concentrations among patients with cirrhosis: effect of dietary protein.
    Fernstrom JD; Wurtman RJ; Hammarstrom-Wiklund B; Rand WM; Munro HN; Davidson CS
    Am J Clin Nutr; 1979 Sep; 32(9):1923-33. PubMed ID: 573062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy of hepatic encephalopathy. Modification of the plasma aminogram using amino acid infusions].
    Ferenci P; Funovics J; Wewalka F
    Chir Forum Exp Klin Forsch; 1978; (1978):183-9. PubMed ID: 110563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics change in serum amino acid levels in different types of hepatic encephalopathy.
    Watanabe A; Hayashi S; Higashi T; Obata T; Sakata T; Takei N; Shiota T; Nagashima H
    Gastroenterol Jpn; 1982; 17(3):218-23. PubMed ID: 7117780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implications of the hyperdynamic syndrome in cirrhosis.
    Licata A; Mazzola A; Ingrassia D; Calvaruso V; Cammà C; Craxì A
    Eur J Intern Med; 2014 Nov; 25(9):795-802. PubMed ID: 25245607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trace amines in hepatic encephalopathy.
    Mousseau DD; Butterworth RF
    Prog Brain Res; 1995; 106():277-84. PubMed ID: 8584664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of hepatic coma.
    Zieve L; Nicoloff DM
    Annu Rev Med; 1975; 26():143-57. PubMed ID: 167647
    [No Abstract]   [Full Text] [Related]  

  • 27. Pathogenesis of hepatic encephalopathy and hyperdynamic syndrome in cirrhosis. Role of false neurotransmitters.
    Nespoli A; Bevilacqua G; Staudacher C; Rossi N; Salerno F; Castelli MR
    Arch Surg; 1981 Sep; 116(9):1129-38. PubMed ID: 6793024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [What about the theory of false neurotransmitters in the hepatic encephalopathy of the cirrhotic patient?].
    Doffoël M; Zarski JP; Marescaux J; Bockel R
    Gastroenterol Clin Biol; 1983 Jan; 7(1):86-94. PubMed ID: 6132851
    [No Abstract]   [Full Text] [Related]  

  • 29. [The dietary protein contribution and hepatic encephalopathy in cirrhosis].
    Zavaglia C; Brivio M; Losacco E; Onida L
    Recenti Prog Med; 1992 Apr; 83(4):218-23. PubMed ID: 1626117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cerebral manifestations in the hepatic coma syndrome (author's transl)].
    Funovics J
    Wien Klin Wochenschr Suppl; 1975; 35():1-16. PubMed ID: 3892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy.
    Holecek M
    Nutrition; 2015 Jan; 31(1):14-20. PubMed ID: 25220875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deranged tyrosine metabolism in cirrhosis.
    Fulenwider JT; Nordlinger BM; Faraj BA; Ivey GL; Rudman D
    Yale J Biol Med; 1978; 51(6):625-33. PubMed ID: 36717
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.